By: John Kurtz & Hannah Basta

Slides:



Advertisements
Similar presentations
Health Care Sector Matt Diffley Marc Travis. Recommendation Short- Term Short- Term Underweight compared to the S&P Underweight compared to the S&P Currently.
Advertisements

Accenture Plc (ACN) Analysts: Chris Landqvist, Justin Pippitt, Kelli Coldiron & Wei Pi.
“Entrepreneurship in the Bio- Medical Equipment Industry” Bio-Medical Engineering National Student Conference Shimon Eckhouse June 18, 2009.
GET RICH QUICK CO. Financial Statement Ratio Analysis: Profitability Long-Term Financial Position Short-Term Financial Position.
National Presto Industries, Inc. Recommendation: Accumulate PRESENTED BY JOE NIEHAUS.
10/19/2009.  Definition: Investing in firm worth more than intrinsic value  Raises the question:  How do we know what a firm is worth?
Chapter 9 An Introduction to Security Valuation. 2 The Investment Decision Process Determine the required rate of return Evaluate the investment to determine.
Selecting Stocks Personal Finance. How hard is it to pick a stock? “ Everyone has the brain power to follow the stock market. If you made it through fifth-grade.
Security Analysis Presentation: Investment Funds Management September 20, 2004.
Jessica Schmidt. Presentation Outline Snapshot Snapshot Past Positions Past Positions Profile Profile History History Current News Current News Financial.
Morgan Stanley December 7th, 2004 By Adam Freda.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
Lecture Presentation Software to accompany Investment Analysis and Portfolio Management Seventh Edition by Frank K. Reilly & Keith C. Brown Chapter 13.
M A Y T E L E C O M S E C T O R : O V E R V I E W Presentation to FIN 824 (SPRING QUARTER) Marc Reitter Siddhesh Sankulkar T E L E C O M S E C.
Eli Lilly and company Matt Spahlinger ACG
Stock Picking Process Stock Picking Process Securities offered through LPL Financial. Member FINRA/SIPC. Stock investing involves risk including loss of.
Motion Picture Industry Presented By Kathy O’Brien Shaun Ryan Matthew Dvorchak.
Hospital Corporation of America Rovi Das ACG
McDonald’s Corporation
Healthcare Sector Analysis Alexander Bishop Justin Gibbs Bethaditya Winarno Jie Zhang.
Business Acumen Training October 8, 2014 JOHNSON & JOHNSON Confidential, unpublished property of Cigna. Do not duplicate or distribute. Use and distribution.
St. Jude Medical Edmundo Lozano June 21, Stock Information Ticker: STJ Price (June 18, 2010): $ week range: $ $42.87.
Analyst: JohnPaul Bennett and Ron Sivick Thursday, September 24 th, 2009.
Healthcare SP-35 Michael Mahaney Tianna Nguyen Edward Poitras Matthew Pry.
Discounted cash flow analysis is the most accurate and flexible method for valuing projects, divisions, and companies. In DCF valuation, the objective.
JOSEPH FARFSING DAVID GARMAN ASH YIJUN GU SCOT HELTON TIMOTHY KEITH Health Care Sector Presentation.
Health Care Sector – Stock Presentation Kailas Joshi Daniel Kurth.
Information Technology Finance 724/824 SIM Class Christopher Moran Suresh Ramasubramanian Sean Ramsey.
MEDTRONIC Fall Foundations 2014 | Business Acumen.
HEALTHCARE Sarah Hemmelgarn Billy Wong Alex Wisler Jason Wattier.
Stericycle Chris Ehley Tom Grove Eric Nichols Zhihao Tong December 4, 2007.
Baxter International Inc. Sadia Ritu. Global Diversified.
Ari Lazar Kyle Castner Jessica Kan Gongsheng Wang Presented April 28, 2015.
Stock Trading 102 Seminar Arlen Novelli, Sesame Chen, Stefan Filipovic and Abby Holtan.
Costco Wholesale Corporation (Costco). Company Overview Industry: Discount Retailers Target Market: Small business owners & 100k earners 417 Warehouse.
Stock Presentation on American Caresource Holdings Timmy Meyer Manu Narra.
Natasha Chou Spring 2013 Student Managed Investment Fund
Stock Market Valuation Valuing Individual Companies.
V Cardiac Equipment Market Size, Share, Global Trends, Company Profile, Demand, Insights, Analysis, Research, Report, Opportunities, Forecast,
Gosreports New Study: Brazil Cardiovascular Devices Market Outlook to 2021.
Seagate Technology PLC Kyle Gesuelli. Which securities fit with the portfolio’s strategy and make sense in the current market? STX comprises largest loss.
 Teva Pharmaceuticals Garrett Hoffman. Agenda  Company Overview  Drivers and Trends  Valuation  Recommendation  WOOF Discusion.
Progress Toward Artificial Pancreas (AP) Systems – A Timeline s 1980s : JDRF.
United States Coronary Stents Market Report 2017.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
USA Insulin Pump Market is expected to grow more than US$ 5 Billion by the end of year 2022.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Tubeless Insulin Pump Market to surpass $2Bn by 2024
Tyler Mumbleau Sunday January 29, 2017
Sang Hyuk Yoon | Tongsu (Serena) Peng
iRobot Equity Report FIN 422 – Student Managed Investment Fund
Tubeless Insulin Pump industry analysis research and trends report for
Kelsey Magraw Juan Fermin James Piccirillo
Global Insulin Delivery System Market Threats, Analysis, Key Players, Growth, and Forecast 2026 July 2017 Copyright © PRUDOUR 2017, All Rights Reserved.
Global Active Implantable Medical Devices Market to Witness 8% CAGR during 2017 – 2023.
Chris Zakhem | Mengxi (Vivian) Wang | Le Huong Hoang | Ziqi (Kay) Mai
Global Insulin Delivery Device Market (Size of $9,998.3 million in 2015) to Witness 6.6% CAGR During.
Growth Opportunities in Global Cardiovascular Device Market :Trends, Forecast, and Opportunity Analysis.
Global Cardiovascular Device Market : Trends, Forecast, and Opportunity Analysis 1.
Connor Roll, Louis Tumukunde, Yuqiao Xue & Ping Zhou
Healthcare Sector Student Investment Management Analysts:
Sang Hyuk Yoon | Tongsu (Serena) Peng
Telecommunication Sector
Overview of Financial Performance for the First Half of FY
Presented: April 26, 2016 Zinjun (Moby) Xu Tianyu (Jack) Shen.
Acquisition Boston Scientific – Guidant
Global Medical Device Market Report : Trends, Forecast and Competitive Analysis 1.
Overview of Financial Performance for the First Half of FY
Stent Market Report : Trends, Forecast and Competitive Analysis 1.
New Advances in Hybrid Closed-Loop Control of Insulin Therapy
Presentation transcript:

By: John Kurtz & Hannah Basta Medtronic, PLC (MDT) By: John Kurtz & Hannah Basta

Company Overview Offers medical equipment in 4 groups: cardiac & vascular, restorative therapies, minimally invasive therapies, and diabetes Specializes in Diabetes management technology Over 3 million Americans suffer from Type 1 Diabetes September 2016: received FDA approval for first closed-loop insulin pump Medtronic MiniMed 670G available for sale Spring 2017 Touted by: JDRF, ADA, WebMD, Time

Financial Overview Current Stock Price: $80.01 52 Week High: $89.27 52 Week Low: $69.35 Market Cap: $109.65 billion November 2016: Voluntary recall of StrataMR(TM) Adjustable Valves & Shunts Recommendation Rating

Financial Overview (ctd.) Total Revenue in 2014: $17.01 billion Total Revenue in 2016: $28.83 billion Gross Profit in 2014: $12.67 billion Gross Profit in 2016: $19.69 billion FY16: 25% increase in dividends ($4.5 billion)

Market Overview Diabetes Tech. Competitors: Animas, Tandem, Insulet Medical Supplies Competitors: Stryker, Boston Scientific, Abbott, Intuitive Surgical 4/7/17 - Citigroup named Medtronic its top sector pick for medical supplies for the rest of 2017, replacing Boston Scientific and Intuitive Surgical None of these companies has developed a closed-loop insulin pump system Endocrinologists are heavily recommending Type 1 Diabetics move onto the MiniMed 670G due to its unique monitoring abilities

Market Share Segment Name Total Revenue Market Share Diabetes 10.41% 36.54% Cardiac Rhythm Mgmt. 31.95% 26.33% Cardiovascular 17.98% 12.48% Neuromodulation 11.96% 20.99% Surgical Tech 9.92% 0.81% Restorative Therapies 39.93% 100% Source: http://csimarket.com/stocks/competitionSEG2.php?code=MDT

Market Comparison Valuation MDT Industry Avg Sector Avg S&P 500 Price/Earnings 28.37 39.66 31.05 25.01 Price/Cash Flow 16.39 21.66 20.19 16.12 Price/Sales 3.49 0.87 1.01 0.77 Price/Book 2.19 4.12 8.12 6.79

Company Risk Product reliability/performance/quality Recall of StrataMR(TM) Adjustable Valves & Shunts Price elasticity Product liability settlement costs Costs to develop/acquire necessary technology upgrades Health insurance plans & cost-containment measures

Spoiler Alert: It’s Good Full Valuation Spoiler Alert: It’s Good